re: News: Suda confirms excellent results fro... Hi Kippax
Yes agreed
I thought the content was excellent. And yes it could have been more broader but the interview was just in relation to the Phase 3 trial results.
As for marketing, I couldnt agree with you more.
SUDA is a compelling investment opportunity with a completed Phase 3 trial as its lead product, and adding to that this product is not just a "me too" product in a crowded marketplace but can make significant inroads in its chosen market given its benefits over existing treatments.
The BRR interview is a good one but yes, we need to get the story out there!
News: Suda confirms excellent results from ArTiMi, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.8¢ | 14.0¢ | $82.17K | 569.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 397956 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 313002 | 7 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |